UNH Stock: RSI 30/70 Mean Reversion Backtest — +30.1% vs -16.0% Buy-and-Hold
Real backtest of the RSI 30/70 Mean Reversion strategy on UNH over 5 years: +30.1% return vs -16.0% buy-and-hold, 14 trades, 29% win rate, 27.0% max drawdown. Computed on real historical data, not simulated — full trade log and verdict inside.
- Total return: +30.1% (beat buy-and-hold at -16.0%)
- Win rate: 29% over 14 trades
- Max drawdown: 27.0%
- Sharpe ratio: 0.17
- Period: 5 years of real historical price data
What the numbers say
On UNH, the RSI 30/70 Mean Reversion beat buy-and-hold over the five years through Nov 2026: +30.1% against -16.0% for simply holding — a gap of 46.1 percentage points. The strategy took 14 completed trades (4 profitable, 10 not), a 29% win rate.
That came with a shallower worst stretch: the strategy's max drawdown was 27.0% versus 61.4% for buy-and-hold. Dollar-cost averaging into UNH over the same window returned -2.1%. Best single trade: +39.4% (2025-07-31 to 2025-09-09); worst: -5.0% (2023-01-05 to 2023-03-09).
Computed by StratIQ's backtest engine on real daily prices through Nov 2026 (generated 2026-11-12). Fills are assumed at the close with a 5% stop-loss; slippage and commissions are not modeled. This is a historical study of a rule — not a pick, not a recommendation, and not financial advice.
A classic mean-reversion setup: buy UnitedHealth (UNH) when the 14-day RSI signals oversold (below 30), sell when it signals overbought (above 70).
Run this exact rule on your own ticker — Test-My-Rule, free · StratIQ Premium: daily picks with exact levels